Last reviewed · How we verify
NCT03573076
Treatment of Photodamaged Skin of the décolleté
Phase 4 trial testing Photodynamic therapy in Photodamaged Skin in 12 participants. Terminated before completion.
18 December 2018
Quick facts
| Lead sponsor | Merete Haedersdal |
|---|---|
| Phase | Phase 4 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 10 September 2018 |
| Primary completion | 18 December 2018 |
| Estimated completion | 18 December 2018 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Photodynamic therapy — full drug profile →
- Non-ablative Thulium laser (NAFL)
- Radio-frequency microneedles (RF-MN)
Conditions studied
- Photodamaged Skin — all drugs for Photodamaged Skin →
Sponsor
Merete Haedersdal — full company profile →
Who can join
18 and older, female only, with Photodamaged Skin. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates a non-ablative fractional thulium laser and a radio-frequency microneedling device as pre-treatment for combination photodynamic therapy in treatment of photoaged skin and actinic keratoses.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Microneedles as a Promising Technology for Disease Monitoring and Drug Delivery: A Review.
Hulimane Shivaswamy R, Binulal P, Benoy A, Lakshmiramanan K, et al · · 2025 · cited 15× · PMID 39802146 · DOI 10.1021/acsmaterialsau.4c00125
Verify or expand the search:
- PubMed search for NCT03573076
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Photodynamic therapy
Trials testing the same drug.
- NCT06485050 — Photodynamic Therapy and Topical Antifungal for Onychomycosis in Patients With Diabetes. · NA · active not recruiting
- NCT05386056 — Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma · Phase 2 · unknown
- NCT04301999 — Clinical Effect and Safety of PDT and RFA for Unresectable EHCC · NA · completed
- NCT03576105 — Evaluation of Photodynamic Therapy in Pericoronitis · NA · unknown
- NCT03591484 — Treatment of Halitosis With Photodynamic Therapy in Older Patients · NA · completed
Other Merete Haedersdal trials
Trials by the same sponsor.
- NCT05937529 — Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis · NA · completed
- NCT05461755 — Treatment of Striae Distensae With Fractional Radiofrequency and Topical Tretinoin · Phase 2 · completed
- NCT05202860 — Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis · Phase 2 · active not recruiting
- NCT05057117 — Longevity of Microwave Thermolysis and Botulinum Toxin A for Treatment of Axillary Hyperhidrosis · Phase 4 · completed
- NCT04221126 — TMFI Enhances Skin Surface and Epidermal PpIX Fluorescence · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03573076 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Merete Haedersdal
- Last refreshed: 10 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03573076.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing